Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNO for Early Pulmonary Hypertension in Preterm Infants
NCT03576885Phase 2Terminated
- Sponsor
- AdventHealth
- Start
- Jul 2019
- Primary completion
- Oct 2023
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in pulmonary hypertension (PH), sponsored by AdventHealth. Started Jul 2019; status: terminated.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT03576885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03576885.